V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20197202 | 20125422 | 1.92 | 106.6 | Palliative (P) | 2021-09-01 | 2021-09-27 | CETUXIMAB | 02 | null | CETUXIMAB | 101129536 |
| 20197205 | 20125423 | 1.78 | 100.75 | Curative (C) | null | 2020-04-29 | Cetuximab 14 day | 99 | Y | CETUXIMAB | 101435345 |
| 20197210 | 20125424 | 1.54 | 57.95 | null | 2018-03-14 | 2018-05-15 | CETUXIMAB | N | N | CETUXIMAB | 101044135 |
| 20197215 | 20125425 | 1.82 | 55.4 | null | 2019-10-01 | 2020-02-13 | Cetuximab 14 day | N | null | CETUXIMAB | 101492003 |
| 20197218 | 20125426 | 1.61 | 78.5 | Palliative (P) | 2017-06-01 | 2017-06-11 | Cetuximab 14 day | N | N | CETUXIMAB | 100437750 |
| 20197222 | 20125427 | 1.66 | 70.1 | Palliative (P) | 2017-11-24 | 2017-11-27 | Cetuximab 14 day | N | N | CAPECITABINE + CISPLATIN | 100988547 |
| 20197230 | 20125428 | 1.75 | 99 | null | 2019-04-29 | 2019-04-29 | CETUXIMAB | 02 | null | CETUXIMAB | 101197492 |
| 20197234 | 20125429 | 1.65 | 73 | Neo-adjuvant (N) | 2019-12-27 | 2020-01-05 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100693828 |
| 20197238 | 20125430 | 1.76 | 88.3 | null | 2016-07-15 | 2016-12-31 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100698040 |
| 20197243 | 20125431 | 1.63 | 76.4 | null | 2018-09-21 | 2018-10-12 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 101383422 |
| 20197248 | 20125432 | 1.62 | 93.8 | Palliative (P) | 2018-12-02 | 2019-03-24 | Trastuzumab 21 day maintenance | N | N | TRASTUZUMAB | 100030487 |
| 20197249 | 20125433 | 1.69 | 67.2 | Palliative (P) | 2016-07-30 | 2016-10-01 | Cetuximab 14 day | N | N | CAPECITABINE + CISPLATIN | 100207563 |
| 20197254 | 20125434 | 1.61 | 60.6 | Palliative (P) | 2019-10-30 | 2019-11-12 | CETUXIMAB | N | N | CAPECITABINE + CISPLATIN | 100092533 |
| 20197257 | 20125435 | 1.65 | 95.8 | 02 | 2015-09-16 | 2017-02-11 | Capecitabine + Cisplatin | N | Y | CAPECITABINE + CISPLATIN | 100331754 |
| 20197258 | 20125436 | 1.61 | 89.6 | Palliative (P) | 2017-11-19 | 2017-11-23 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101057869 |
| 20197259 | 20125437 | 1.76 | null | Palliative (P) | 2018-03-31 | 2018-04-07 | Trastuzumab | N | N | TRASTUZUMAB | 100471982 |
| 20197261 | 20125438 | 1.69 | 68 | null | 2018-05-01 | 2018-08-06 | Cetuximab 14 day | N | null | CETUXIMAB | 101462130 |
| 20197268 | 20125439 | 1.7 | 75.4 | Neo-adjuvant (N) | 2018-09-14 | 2020-08-08 | CETUXIMAB | 2 | N | CETUXIMAB | 100037947 |
| 20197269 | 20125440 | 1.8 | 57.3 | Palliative (P) | 2019-11-18 | 2019-11-19 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100827286 |
| 20197270 | 20125441 | 1.8 | 78.5 | Curative (C) | 2018-07-05 | 2018-07-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100272970 |
| 20197277 | 20125442 | 1.8 | 83.6 | Adjuvant (A) | 2016-08-20 | 2016-09-11 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101518923 |
| 20197278 | 20125443 | 1.72 | 88.95 | Curative (C) | 2018-07-15 | 2018-07-28 | CETUXIMAB | 02 | Y | CETUXIMAB | 100874418 |
| 20197286 | 20125444 | 1.59 | 54 | null | 2017-05-08 | 2017-05-22 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101635139 |
| 20197290 | 20125445 | 1.62 | null | Adjuvant (A) | 2019-04-20 | 2019-12-03 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101703340 |
| 20197292 | 20125446 | 1.72 | 82.3 | Palliative (P) | 2016-11-27 | 2018-11-10 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100702342 |
| 20197293 | 20125447 | 1.55 | 73.8 | Adjuvant (A) | 2017-04-17 | 2017-05-06 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100648698 |
| 20197297 | 20125448 | 1.72 | 47 | Adjuvant (A) | 2017-08-22 | 2018-06-18 | CETUXIMAB | 02 | N | CETUXIMAB | 101126690 |
| 20197304 | 20125449 | 1.88 | 58 | Neo-adjuvant (N) | 2017-08-15 | 2017-08-24 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100984163 |
| 20197307 | 20125450 | 1.75 | 78.25 | null | 2019-04-10 | 2019-05-10 | CETUXIMAB | 02 | null | CETUXIMAB | 101213669 |
| 20197309 | 20125451 | 1.7 | 51.8 | Curative (C) | 2018-09-12 | 2018-09-12 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101791767 |
| 20197315 | 20125452 | null | null | Neo-adjuvant (N) | 2018-11-03 | 2018-11-03 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101773479 |
| 20197318 | 20125453 | 1.66 | 83.8 | Curative (C) | 2019-02-04 | 2019-02-18 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100359019 |
| 20197319 | 20125454 | 1.52 | 71 | Neo-adjuvant (N) | 2019-05-05 | 2019-05-14 | CETUXIMAB | 02 | N | CETUXIMAB | 101300435 |
| 20197321 | 20125455 | 1.7 | 64.6 | Curative (C) | 2018-09-10 | 2018-09-11 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101817281 |
| 20197326 | 20125456 | 1.64 | 74.1 | Palliative (P) | 2018-10-30 | 2018-11-15 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101739222 |
| 20197327 | 20125457 | 1.66 | null | Curative (C) | null | 2018-01-28 | Trastuzumab | 02 | null | TRASTUZUMAB | 100434794 |
| 20197329 | 20125458 | 1.65 | 75.9 | null | 2017-05-02 | 2017-05-24 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100999731 |
| 20197332 | 20125459 | 1.9 | 60.9 | Curative (C) | 2016-11-17 | 2016-11-21 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100201567 |
| 20197336 | 20125460 | 1.62 | 57.2 | Adjuvant (A) | 2017-04-14 | 2017-05-05 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100074300 |
| 20197339 | 20125461 | 1.57 | 63.5 | Curative (C) | 2020-03-03 | 2020-03-03 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100452769 |
| 20197341 | 20125462 | 1.83 | 78.5 | Neo-adjuvant (N) | 2016-02-28 | 2016-03-05 | CETUXIMAB | 02 | N | CETUXIMAB | 101263408 |
| 20197342 | 20125463 | 1.8 | 74.05 | Curative (C) | 2019-03-15 | 2019-09-08 | Trastuzumab | 02 | N | TRASTUZUMAB | 100925074 |
| 20197344 | 20125464 | 1.69 | 93 | Neo-adjuvant (N) | 2017-01-13 | 2017-01-16 | Trastuzumab | 02 | N | TRASTUZUMAB | 100810356 |
| 20197347 | 20125465 | 1.72 | 75 | Adjuvant (A) | 2016-03-29 | 2016-04-16 | CETUXIMAB | 02 | N | CETUXIMAB | 100837951 |
| 20197352 | 20125466 | 1.83 | 51 | null | 2019-02-12 | 2019-02-20 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100798270 |
| 20197358 | 20125467 | 1.73 | 71.8 | Palliative (P) | 2018-08-23 | 2018-09-07 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101098598 |
| 20197361 | 20125468 | 1.87 | 80 | Curative (C) | 2017-04-27 | 2017-05-16 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100345767 |
| 20197362 | 20125469 | 1.73 | 62.6 | Palliative (P) | 2018-02-04 | 2018-02-27 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101457039 |
| 20197365 | 20125470 | 1.73 | 84 | Palliative (P) | 2018-01-29 | 2019-04-25 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101199940 |
| 20197367 | 20125471 | 1.92 | 66.5 | 03 | 2017-10-05 | 2018-01-08 | Trastuzumab | 02 | N | TRASTUZUMAB | 100845083 |